Paul F. Koster
- Hematology top 5%
- Molecular Biology
- Cardiology and Cardiovascular Medicine
- Internal Medicine top 5%
- Immunology and Allergy top 10%
- Co-authors
- Richard E. ValocikJohn R. ToomeyAndrew J. NicholsDrake S. EgglestonCatherine E. PeishoffJohn W. BeanGiora FeuersteinEliot H. Ohlstein
- Topics
- Blood Coagulation and Thrombosis Mechanisms (5 papers)Venous Thromboembolism Diagnosis and Management (5 papers)Platelet Disorders and Treatments (4 papers)
- Partner nations
- United StatesUnited KingdomBrazil
In The Last Decade
Paul F. Koster
21 papers receiving 447 citations
Peers
Comparison fields: 5 of 67
- Hematology 170
- Molecular Biology 153
- Cardiology and Cardiovascular Medicine 134
- Internal Medicine 85
- Immunology and Allergy 80
Countries citing papers authored by Paul F. Koster
This map shows the geographic impact of Paul F. Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul F. Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul F. Koster more than expected).
Fields of papers citing papers by Paul F. Koster
This network shows the impact of papers produced by Paul F. Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul F. Koster. The network helps show where Paul F. Koster may publish in the future.
Co-authorship network of co-authors of Paul F. Koster
This figure shows the co-authorship network connecting the top 25 collaborators of Paul F. Koster. A scholar is included among the top collaborators of Paul F. Koster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul F. Koster. Paul F. Koster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 31 | |
| 3 | 5 | |
| 4 | 44 | |
| 5 | 30 | |
| 6 | 63 | |
| 7 | 41 | |
| 8 | 13 | |
| 9 | The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760. | 7 |
| 10 | 78 | |
| 11 | 56 | |
| 12 | 15 | |
| 13 | 3 | |
| 14 | 13 | |
| 15 | 25 | |
| 16 | 12 | |
| 17 | 7 | |
| 18 | SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta). | 16 |
| 19 | 7 | |
| 20 | 4 |
About Paul F. Koster
Paul F. Koster is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 21 papers that have together received 481 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Platelet Disorders and Treatments (4 papers). The work is most often cited by research in Internal Medicine (85 citations), Hematology (170 citations) and Immunology and Allergy (80 citations). Paul F. Koster has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Richard E. Valocik, John R. Toomey, Andrew J. Nichols, Drake S. Eggleston, Catherine E. Peishoff, John W. Bean, Giora Feuerstein, Eliot H. Ohlstein, David P. Brooks and Michael N. Blackburn. Their work appears in journals such as Stroke, Journal of Medicinal Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.